Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells

GLIA

Volumn 55, Issue 7, 2007, Pages 772-776

  Duan, Rui Sheng ^a   Jin, Tao ^a,b   Yang, Xin ^a,b   Mix, Eilhard ^c   Adem, Abdu ^d   Zhu, Jie ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Antigen presentation; Apolipoprotein E; Co stimulatory molecule; MHC II; Schwann cells

Indexed keywords

APOLIPOPROTEIN E; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HYPERLIPOPROTEINEMIA TYPE 3; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; APOLIPOPROTEINS E; CELL PROLIFERATION; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN P0 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PERIPHERAL NERVES; POLYRADICULONEUROPATHY; SCHWANN CELLS; T-LYMPHOCYTES; UP-REGULATION;

EID: 34247526332     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20498     Document Type: Article

References (23)

1. Argall KG, Armati PJ, Pollard JD, Watson E, Bonner J. 1992. Interactions between CD4+ T-cells and rat Schwann cells in vitro. I. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines. J Neuroimmunol 40:1-18.
2. Armati PJ, Pollard JD, Gatenby P. 1990. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13:106-116.
3. Avila EM, Holdsworth G, Sasaki N, Jackson RL, Harmony JA. 1982. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J Biol Chem 257:5900-5909.
4. Chapman J, Sylantiev C, Nisipeanu P, Korczyn AD. 1999. Preliminary observations on APOE ε4 allele and progression of disability in multiple sclerosis. Arch Neurol 56:1484-1487.
5. Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD. 2001. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56:312-316.
6. Gold R, Toyka KV, Hartung HP. 1995. Synergistic effect of IFN-γ and TNF-α on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165:65-70.
7. Hirano T. 1998. Interleukin 6 and its receptor: Ten years later. Int Rev Immunol 16:249-284.
8. Jones SA. 2005. Directing transition from innate to acquired immunity: Defining a role for IL-6. J Immunol 175:3463-3468.
9. Karussis D, Michaelson DM, Grigoriadis N, Korezyn AD, Mizrachi-Koll R, Chapman S, Abramsky O, Chapman J. 2003. Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis. Mult Scler 9:476-480.
10. Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T. 2005. IL-6-STAT3 controls intracellular MHC class II αβ dimer level through cathepsin S activity in dendritic cells. Immunity 23:491-502.
11. Koski CL. 1997. Mechanisms of Schwann cell damage in inflammatory neuropathy. J Infect Dis 176(Suppl 2):S169-S172.
12. Laskowitz DT, Lee DM, Schmechel D, Staats HF. 2000. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 41:613-620.
13. Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, Nicoletti A. 2001. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104:197-202.
14. Lilje O, Armati PJ. 1997. The distribution and abundance of MHC, ICAM-1 on Schwann cells in vitro. J Neuroimmunol 77:75-84.
15. Macy M, Okano Y, Cardin AD, Avila EM, Harmony JA. 1983. Suppression of lymphocyte activation by plasma lipoproteins. Cancer Res 43:2496s-2502s.
16. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
17. Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173:3844-3854.
18. Pollard JD, Baverstock J, McLeod JG. 1987. Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann Neurol 21:337-341.
19. Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG. 1986. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 13:123-134.
20. Sylantiev C, Chapman J, Chilkevich O, Nisipeanu P, Chistik V, Korczyn A. 1998. The APOE 4 allele and progression of disability in multiple sclerosis. Neurology 50(Suppl):P03060.
21. Tenger C, Zhou X. 2003. Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. Immunology 109:392-397.
22. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, Gold R. 2000. Regulation of Fas and FasL expression on rat Schwann cells. Glia 30:373-381.
23. Yu S, Duan RS, Chen Z, Quezada HC, Bao L, Nennesmo I, Zhu SW, Winblad B, Ljunggren HG, Zhu J. 2004. Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice. J Neuropathol Exp Neurol 63:120-128.